封面
市場調查報告書
商品編碼
2108381

聚葡萄糖市場分析及預測(至2035年):類型、產品、技術、成分、應用、形態、製程、最終用戶、功能

Glucan Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Form, Process, End User, Functionality

出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球聚葡萄糖市場預計將從2025年的7億美元成長到2035年的14億美元,複合年成長率(CAGR)為7.5%。聚葡萄糖成長主要得益於BETA-葡聚醣成分在食品和營養保健品應用領域持續獲得科學檢驗和監管批准。 2025年,歐洲食品安全局(EFSA)發布了最新的科學研究結果,支持燕麥和大麥來源的BETA-葡聚醣能夠抑制餐後血糖值峰值的健康功效,從而促進其在歐洲功能性食品配方中的應用。預計這項監管批准將進一步加速BETA-葡聚醣成分在膳食補充劑、功能性食品、飲料和臨床營養產品中的商業化進程。

聚葡萄糖市場按類型可分為BETA-葡聚醣、α-葡聚醣和其他類型。 BETA-葡聚醣因其科學驗證的健康益處而佔市場主導地位,例如增強免疫系統、降低膽固醇、控制血糖值和改善消化器官系統健康。 BETA-葡聚醣廣泛來自燕麥、大麥、酵母、蘑菇等,並應用於功能性食品、營養保健品和藥品。 α-葡聚醣也因其在食品配料、化妝品和生物技術領域的應用而備受關注。消費者對天然和植物來源的健康成分日益成長的偏好,並持續推動各類聚葡萄糖的需求成長。

市場區隔
類型 BETA-葡聚醣、α-葡聚醣及其他
產品 穀物來源的聚葡萄糖、酵母來源的聚葡萄糖、蘑菇來源的聚葡萄糖、海藻來源的聚葡萄糖等。
科技 生物技術、酵素提取及其他
成分 活性成分、添加劑及其他
目的 食品和飲料、藥品、化妝品和個人護理產品、動物飼料、營養補充劑、功能性食品、膳食補充劑等。
形式 粉末、液體、膠囊、片劑、其他
流程 提取、發酵、純化及其他製程。
最終用戶 食品業、製藥業、化妝品業、動物飼料業及其他行業
功能 免疫健康、膽固醇管理、血糖值管理、消化健康等等。

聚葡萄糖市場的「終端用戶」部分涵蓋食品、製藥、化妝品和動物飼料產業。食品產業佔了較大的市場佔有率,這主要歸功於聚葡萄糖擴大被添加到功能性食品、飲料和膳食補充劑中,以增強其營養價值和健康益處。製藥業正在擴大聚葡萄糖在免疫支持配方和治療產品中的應用,而化妝品行業則將聚葡萄糖用於皮膚保濕和抗衰老。動物營養產業也正在採用聚葡萄糖作為天然飼料添加劑,以提高牲畜的免疫力和整體健康狀況。

區域概覽

到2025年,北美將佔全球聚葡萄糖市場最大佔有率。這主要得益於功能性成分需求的成長、健康意識的提高以及聚葡萄糖基產品在營養保健品、製藥、食品飲料和動物營養等領域的廣泛應用。美國和加拿大是推動市場成長的主要地區,這得益於消費者對免疫支持補充劑的濃厚興趣、成熟的膳食補充劑行業以及對健康和保健產品的大量投資。該地區受益於大型生物技術公司的存在、先進的研發能力以及BETA-葡聚醣成分在功能性食品和預防性藥物產品中的廣泛應用。此外,對天然生物活性化合物的需求不斷成長、對免疫健康的日益關注以及聚葡萄糖在個性化營養解決方案中的應用日益廣泛,都進一步鞏固了北美在全球聚葡萄糖市場的主導地位。

預計在預測期內,亞太地區聚葡萄糖市場將保持最高成長率,這主要得益於健康意識的增強、營養保健品產業的擴張以及功能性食品和膳食補充劑的普及。隨著消費者對增強免疫力、預防疾病和天然保健產品的興趣日益濃厚,中國、日本、印度、韓國和澳洲等國家對聚葡萄糖類成分的需求正在不斷成長。該地區擁有龐大的人口基數、完善的醫療基礎設施以及對生物技術和食品配料創新領域不斷增加的投資,這些都為市場成長提供了有利條件。此外,可支配收入的增加、人們對BETA-葡聚醣益處的認知不斷提高以及其在製藥、化妝品和動物飼料等領域的應用不斷拓展,都在加速市場成長,使亞太地區成為聚葡萄糖產品成長最快的區域市場。

主要趨勢和促進因素

BETA-葡聚醣在功能性食品和免疫健康產品的應用日益廣泛

在聚葡萄糖市場,消費者對預防醫學和免疫支持的日益關注正推動BETA-葡聚醣成分配方在功能性食品、膳食補充劑和營養保健品中的應用不斷擴展。源自燕麥、酵母和蘑菇等的BETA-葡聚醣因其廣為人知的健康益處而備受青睞,這些益處包括增強免疫系統、控制膽固醇和改善腸道健康。食品和飲料生產商正不斷開發含有聚葡萄糖的功能性食品,例如穀物、飲料、膳食補充劑和健康產品。消費者對潔淨標示、天然來源和健康成分的需求不斷成長,正在推動創新,並促進聚葡萄糖在營養保健領域的應用全面擴展。

消費者對增強免疫力、促進健康的成分需求日益成長。

人們對免疫健康、功能性營養和預防保健的日益關注是聚葡萄糖市場的主要驅動力。消費者越來越傾向於選擇天然的、具有生物活性的成分,以期獲得超越基本營養的健康益處,從而推動了對聚葡萄糖補充劑和強化食品的需求。文明病的日益普遍以及人們對維護心血管和消化器官系統健康的日益重視,進一步促進了BETA-葡聚醣作為原料的應用。此外,製藥公司、營養保健品公司和食品製造商也在加大對聚葡萄糖在免疫支持配方、膳食補充劑和治療應用方面的研發投入,從而推動了市場的持續成長。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章:細分市場分析

  • 市場規模及預測:依類型
    • BETA-葡聚醣
    • α-葡聚醣
    • 其他
  • 市場規模及預測:依產品分類
    • 穀物來源的聚葡萄糖
    • 酵母來源的聚葡萄糖
    • 蘑菇來源的聚葡萄糖
    • 海藻來源的聚葡萄糖
    • 其他
  • 市場規模及預測:依應用領域分類
    • 飲食
    • 製藥
    • 化妝品和個人護理
    • 動物飼料
    • 營養補充品
    • 功能性食品
    • 營養補充品
    • 其他
  • 市場規模及預測:依類型
    • 粉末
    • 液體
    • 膠囊
    • 藥片
    • 其他
  • 市場規模及預測:依最終用戶分類
    • 食品工業
    • 製藥業
    • 化妝品產業
    • 動物飼料業
    • 其他
  • 市場規模及預測:依功能分類
    • 免疫健康
    • 膽固醇管理
    • 血糖值管理
    • 消化系統健康
    • 其他
  • 市場規模及預測:依製程分類
    • 萃取
    • 發酵
    • 純化
    • 其他
  • 市場規模及預測:依技術分類
    • 生物技術
    • 酵素提取
    • 其他
  • 市場規模及預測:依組件分類
    • 活性成分
    • 添加劑
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 定價和成本利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章:公司簡介

  • Cargill
  • Tate & Lyle
  • Kerry Group
  • DSM
  • Ingredion
  • Lesaffre
  • ABF Ingredients
  • Angel Yeast
  • Biorigin
  • Lallemand
  • Ohly
  • Alltech
  • BIoTec Pharmacon
  • Garuda International
  • Super Beta Glucan
  • AHD International
  • BIoThera Pharmaceuticals
  • Ceapro
  • NutraQ
  • BetaBioTech

第9章 關於我們

簡介目錄
Product Code: GIS34729

The global Glucan Market is projected to grow from $0.7 billion in 2025 to $1.4 billion by 2035, at a compound annual growth rate (CAGR) of 7.5%. The glucan market is supported by expanding scientific validation and regulatory recognition of B-glucan ingredients for food and nutraceutical applications. In 2025, the European Food Safety Authority published an updated scientific opinion confirming the health claim for oat and barley B-glucans in reducing postprandial glycaemic responses, reinforcing their use in functional food formulations across Europe. This regulatory validation is expected to support wider commercialization of B-glucan ingredients in dietary supplements, functional foods, beverages, and clinical nutrition products.

The Type segment of the Glucan Market includes beta-glucan, alpha-glucan, and others. Beta-glucan represents the dominant market segment due to its scientifically validated health benefits, including immune system support, cholesterol reduction, blood sugar management, and digestive health improvement. It is widely sourced from oats, barley, yeast, and mushrooms for use in functional foods, nutraceuticals, and pharmaceutical products. Alpha-glucan is also gaining attention for its applications in food ingredients, cosmetics, and biotechnology. Increasing consumer preference for natural and plant-based health ingredients continues to drive demand across glucan types.

Market Segmentation
TypeBeta-Glucan, Alpha-Glucan, Others
ProductCereal-based Glucan, Yeast-based Glucan, Mushroom-based Glucan, Seaweed-based Glucan, Others
TechnologyBiotechnology, Enzymatic Extraction, Others
ComponentActive Ingredient, Additive, Others
ApplicationFood & Beverages, Pharmaceuticals, Cosmetics & Personal Care, Animal Feed, Nutraceuticals, Functional Foods, Dietary Supplements, Others
FormPowder, Liquid, Capsules, Tablets, Others
ProcessExtraction, Fermentation, Purification, Others
End UserFood Industry, Pharmaceutical Industry, Cosmetic Industry, Animal Nutrition Industry, Others
FunctionalityImmune Health, Cholesterol Management, Blood Sugar Management, Digestive Health, Others

The End User segment of the Glucan Market includes the food industry, pharmaceutical industry, cosmetic industry, animal nutrition industry, and others. The food industry accounts for a significant market share due to the increasing incorporation of glucan into functional foods, beverages, and dietary supplements to enhance nutritional value and health benefits. The pharmaceutical industry is expanding its use of glucan in immune-support formulations and therapeutic products, while the cosmetic industry utilizes glucan for skin hydration and anti-aging applications. The animal nutrition industry is also adopting glucan as a natural feed additive to improve immunity and overall livestock health.

Geographical Overview

North America held the largest share of the global Glucan Market in 2025, supported by increasing demand for functional ingredients, growing health awareness, and expanding applications of glucan-based products across nutraceuticals, pharmaceuticals, food & beverages, and animal nutrition sectors. The United States and Canada are major contributors due to strong consumer interest in immune-supporting supplements, well-established dietary supplement industries, and significant investments in health and wellness products. The region benefits from the presence of leading biotechnology companies, advanced research capabilities, and widespread adoption of beta-glucan ingredients in functional foods and preventive healthcare products. Furthermore, rising demand for natural bioactive compounds, increasing focus on immune health, and growing incorporation of glucans into personalized nutrition solutions are strengthening North Americas leadership in the global glucan market.

The Asia Pacific Glucan Market is expected to register the highest growth during the forecast period, driven by rising health consciousness, expanding nutraceutical industries, and increasing adoption of functional foods and dietary supplements. Countries such as China, Japan, India, South Korea, and Australia are witnessing growing demand for glucan-based ingredients due to increasing consumer focus on immunity enhancement, preventive healthcare, and natural wellness products. The region benefits from a large population base, improving healthcare infrastructure, and growing investments in biotechnology and food ingredient innovation. Additionally, rising disposable incomes, increasing awareness of the benefits of beta-glucans, and expanding applications in pharmaceuticals, cosmetics, and animal feed are accelerating market growth, positioning Asia Pacific as the fastest-growing regional market for glucan products.

Key Trends and Drivers

Growing Adoption of Beta-Glucan in Functional Foods and Immune Health Products:

The Glucan Market is witnessing a growing trend toward the incorporation of beta-glucan ingredients in functional foods, dietary supplements, and nutraceutical products due to increasing consumer focus on preventive healthcare and immune support. Beta-glucans derived from sources such as oats, yeast, and mushrooms are gaining popularity for their recognized health benefits, including immune system support, cholesterol management, and improved gut health. Food and beverage manufacturers are increasingly developing fortified products such as cereals, beverages, supplements, and wellness formulations containing glucan ingredients. The rising demand for clean-label, natural, and health-oriented ingredients is encouraging innovation and expanding applications of glucans across the nutrition and healthcare sectors.

Increasing Consumer Demand for Immunity-Boosting and Health-Enhancing Ingredients:

The rising awareness of immune health, functional nutrition, and preventive wellness is a major driver of the Glucan Market. Consumers are increasingly seeking natural bioactive ingredients that provide additional health benefits beyond basic nutrition, increasing demand for glucan-based supplements and fortified food products. The growing prevalence of lifestyle-related health concerns and increasing interest in maintaining cardiovascular and digestive health are further supporting the adoption of beta-glucan ingredients. Additionally, pharmaceutical, nutraceutical, and food companies are investing in research and product development to utilize glucans in immune-support formulations, dietary supplements, and therapeutic applications, contributing to sustained market growth.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Application
  • 2.4 Key Market Highlights by Form
  • 2.5 Key Market Highlights by End User
  • 2.6 Key Market Highlights by Functionality
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Technology
  • 2.9 Key Market Highlights by Component

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Beta-Glucan
    • 4.1.2 Alpha-Glucan
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Cereal-based Glucan
    • 4.2.2 Yeast-based Glucan
    • 4.2.3 Mushroom-based Glucan
    • 4.2.4 Seaweed-based Glucan
    • 4.2.5 Others
  • 4.3 Market Size & Forecast by Application (2020-2035)
    • 4.3.1 Food & Beverages
    • 4.3.2 Pharmaceuticals
    • 4.3.3 Cosmetics & Personal Care
    • 4.3.4 Animal Feed
    • 4.3.5 Nutraceuticals
    • 4.3.6 Functional Foods
    • 4.3.7 Dietary Supplements
    • 4.3.8 Others
  • 4.4 Market Size & Forecast by Form (2020-2035)
    • 4.4.1 Powder
    • 4.4.2 Liquid
    • 4.4.3 Capsules
    • 4.4.4 Tablets
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by End User (2020-2035)
    • 4.5.1 Food Industry
    • 4.5.2 Pharmaceutical Industry
    • 4.5.3 Cosmetic Industry
    • 4.5.4 Animal Nutrition Industry
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by Functionality (2020-2035)
    • 4.6.1 Immune Health
    • 4.6.2 Cholesterol Management
    • 4.6.3 Blood Sugar Management
    • 4.6.4 Digestive Health
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Extraction
    • 4.7.2 Fermentation
    • 4.7.3 Purification
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Technology (2020-2035)
    • 4.8.1 Biotechnology
    • 4.8.2 Enzymatic Extraction
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Component (2020-2035)
    • 4.9.1 Active Ingredient
    • 4.9.2 Additive
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Application
      • 5.2.1.4 Form
      • 5.2.1.5 End User
      • 5.2.1.6 Functionality
      • 5.2.1.7 Process
      • 5.2.1.8 Technology
      • 5.2.1.9 Component
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Application
      • 5.2.2.4 Form
      • 5.2.2.5 End User
      • 5.2.2.6 Functionality
      • 5.2.2.7 Process
      • 5.2.2.8 Technology
      • 5.2.2.9 Component
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Application
      • 5.2.3.4 Form
      • 5.2.3.5 End User
      • 5.2.3.6 Functionality
      • 5.2.3.7 Process
      • 5.2.3.8 Technology
      • 5.2.3.9 Component
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Application
      • 5.3.1.4 Form
      • 5.3.1.5 End User
      • 5.3.1.6 Functionality
      • 5.3.1.7 Process
      • 5.3.1.8 Technology
      • 5.3.1.9 Component
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Application
      • 5.3.2.4 Form
      • 5.3.2.5 End User
      • 5.3.2.6 Functionality
      • 5.3.2.7 Process
      • 5.3.2.8 Technology
      • 5.3.2.9 Component
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Application
      • 5.3.3.4 Form
      • 5.3.3.5 End User
      • 5.3.3.6 Functionality
      • 5.3.3.7 Process
      • 5.3.3.8 Technology
      • 5.3.3.9 Component
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Application
      • 5.4.1.4 Form
      • 5.4.1.5 End User
      • 5.4.1.6 Functionality
      • 5.4.1.7 Process
      • 5.4.1.8 Technology
      • 5.4.1.9 Component
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Application
      • 5.4.2.4 Form
      • 5.4.2.5 End User
      • 5.4.2.6 Functionality
      • 5.4.2.7 Process
      • 5.4.2.8 Technology
      • 5.4.2.9 Component
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Application
      • 5.4.3.4 Form
      • 5.4.3.5 End User
      • 5.4.3.6 Functionality
      • 5.4.3.7 Process
      • 5.4.3.8 Technology
      • 5.4.3.9 Component
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Application
      • 5.4.4.4 Form
      • 5.4.4.5 End User
      • 5.4.4.6 Functionality
      • 5.4.4.7 Process
      • 5.4.4.8 Technology
      • 5.4.4.9 Component
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Application
      • 5.4.5.4 Form
      • 5.4.5.5 End User
      • 5.4.5.6 Functionality
      • 5.4.5.7 Process
      • 5.4.5.8 Technology
      • 5.4.5.9 Component
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Application
      • 5.4.6.4 Form
      • 5.4.6.5 End User
      • 5.4.6.6 Functionality
      • 5.4.6.7 Process
      • 5.4.6.8 Technology
      • 5.4.6.9 Component
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Application
      • 5.4.7.4 Form
      • 5.4.7.5 End User
      • 5.4.7.6 Functionality
      • 5.4.7.7 Process
      • 5.4.7.8 Technology
      • 5.4.7.9 Component
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Application
      • 5.5.1.4 Form
      • 5.5.1.5 End User
      • 5.5.1.6 Functionality
      • 5.5.1.7 Process
      • 5.5.1.8 Technology
      • 5.5.1.9 Component
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Application
      • 5.5.2.4 Form
      • 5.5.2.5 End User
      • 5.5.2.6 Functionality
      • 5.5.2.7 Process
      • 5.5.2.8 Technology
      • 5.5.2.9 Component
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Application
      • 5.5.3.4 Form
      • 5.5.3.5 End User
      • 5.5.3.6 Functionality
      • 5.5.3.7 Process
      • 5.5.3.8 Technology
      • 5.5.3.9 Component
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Application
      • 5.5.4.4 Form
      • 5.5.4.5 End User
      • 5.5.4.6 Functionality
      • 5.5.4.7 Process
      • 5.5.4.8 Technology
      • 5.5.4.9 Component
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Application
      • 5.5.5.4 Form
      • 5.5.5.5 End User
      • 5.5.5.6 Functionality
      • 5.5.5.7 Process
      • 5.5.5.8 Technology
      • 5.5.5.9 Component
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Application
      • 5.5.6.4 Form
      • 5.5.6.5 End User
      • 5.5.6.6 Functionality
      • 5.5.6.7 Process
      • 5.5.6.8 Technology
      • 5.5.6.9 Component
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Application
      • 5.6.1.4 Form
      • 5.6.1.5 End User
      • 5.6.1.6 Functionality
      • 5.6.1.7 Process
      • 5.6.1.8 Technology
      • 5.6.1.9 Component
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Application
      • 5.6.2.4 Form
      • 5.6.2.5 End User
      • 5.6.2.6 Functionality
      • 5.6.2.7 Process
      • 5.6.2.8 Technology
      • 5.6.2.9 Component
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Application
      • 5.6.3.4 Form
      • 5.6.3.5 End User
      • 5.6.3.6 Functionality
      • 5.6.3.7 Process
      • 5.6.3.8 Technology
      • 5.6.3.9 Component
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Application
      • 5.6.4.4 Form
      • 5.6.4.5 End User
      • 5.6.4.6 Functionality
      • 5.6.4.7 Process
      • 5.6.4.8 Technology
      • 5.6.4.9 Component
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Application
      • 5.6.5.4 Form
      • 5.6.5.5 End User
      • 5.6.5.6 Functionality
      • 5.6.5.7 Process
      • 5.6.5.8 Technology
      • 5.6.5.9 Component

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Cargill
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Tate & Lyle
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Kerry Group
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 DSM
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Ingredion
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Lesaffre
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 ABF Ingredients
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Angel Yeast
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Biorigin
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Lallemand
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Ohly
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Alltech
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Biotec Pharmacon
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Garuda International
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Super Beta Glucan
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 AHD International
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Biothera Pharmaceuticals
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Ceapro
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 NutraQ
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 BetaBioTech
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us